InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,555.74
(
-0.16%
)
US TECH 100
19,042.00
(
-0.95%
)
Dow Jones
40,358.09
(
-0.14%
)
Brent Oil
80.71
(
-0.09%
)
Bitcoin
66,450.69
(
0.80%
)
Post# of 252658
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

jbog

Send PM Follow Ignore
Followers 60
Posts 11537
Boards Moderated 0
Alias Born 07/16/2006

jbog

Member Level

Re: DewDiligence post# 171576

Thursday, 12/19/2013 10:44:16 PM

Thursday, December 19, 2013 10:44:16 PM

Post# of 252658
Dew

Note that NVS’ Humira-FoB program, which is using the conventional BLA pathway in the US, is not seeking US interchangeability with branded Humira. This makes it a very different business proposition from what BAX/MNTA are attempting to do with their FoB compounds.



That is understood, but I'd guess their pathway will also be many years faster.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up